In the BioHarmony Drug Report Database

"Preview" Icon

Rosuvastatin

Crestor, Ezallor Sprinkle (rosuvastatin) is a small molecule pharmaceutical. Rosuvastatin was first approved as Crestor on 2003-08-12. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. Crestor’s patents are valid until 2036-02-12 (FDA).

 

Trade Name

 

Crestor, Ezallor Sprinkle
 

Common Name

 

rosuvastatin
 

ChEMBL ID

 

CHEMBL1496
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Rosuvastatin structure rendering